(Source: Terumo Corporation) July 1, 2013 Tokyo - Terumo Corporation (TSE: 4543 Section 1) announced that it has entered a strategic alliance as of June 30, 2013 with Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, in the development of the smallest full capacity, next generation implantable left ventricular assist system using a unique centrifugal blood pump, DuraHeart® II (hereafter "DH-II"). The alliance includes the sale of certain assets and licensing of intellectual properties related to DH-II. Thoratec will continue...
↧